SCHEMBL4808302

SCHEMBL4808302

CN1CCN(Cc2cccc(N)c2N)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
CHRNA7 P36544 1/20 0.49
MC4R P32245 1/20 0.49
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.47
NR1H2 P55055 1/20 0.47
HTR6 P50406 3/20 0.45
CA2 P00918 1/20 0.45
NCF1 P14598 1/20 0.45
CHKA P35790 1/20 0.45
PRMT6 Q96LA8 1/20 0.45
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
ADRA2C P18825 1/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MPO P05164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3412153 0.86 MC4R (0.56) LMNACHRNA7MC4RKDM4EALDH1A1
SCHEMBL22169239 0.85 KMT2A (0.51) LMNACHRNA7MC4RKDM4EALDH1A1
SCHEMBL309875 0.85 LMNA (0.49) LMNACHRNA7MC4RKDM4EALDH1A1
SCHEMBL24113849 0.83 KDM4E (0.48) LMNACHRNA7MC4RKDM4EALDH1A1
SCHEMBL18658782 0.83 LMNA (0.51) LMNACHRNA7MC4RKDM4EALDH1A1
SCHEMBL22169121 0.81 DRD2 (0.52) LMNAKDM4EALDH1A1POLBHTR6
SCHEMBL5498471 0.80 ALDH1A1 (0.55) LMNACHRNA7MC4RKDM4EALDH1A1
SCHEMBL31172442 0.79 CYP2A13 (0.57) LMNAKDM4EALDH1A1NCF1ADORA2A
SCHEMBL6055273 0.79 CYP2A13 (0.57) LMNAKDM4EALDH1A1NCF1ADORA2A
SCHEMBL14407776 0.75 MPO (0.57) KDM4EALDH1A1CYP2D6MPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778936-B2 Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases ASTEX THERAPEUTICS LIMITED (GB) 2014-07-15 US disclosed
EP-1968579-A1 PHARMACEUTICAL COMPOUNDS Astex Therapeutics Limited (GB) 2008-09-17 EP disclosed
WO-2007077435-A1 PHARMACEUTICAL COMPOUNDS ASTEX THERAPEUTICS LIMITED (GB) 2007-07-12 WO disclosed